Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer [Phase 2]
Phase 2 randomized trial of genomically directed therapy in triple-negative breast cancer completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: 18F-fluoroestradiol (FES) PET/CT for Breast Cancer [Phase 2]
Phase 2 clinical trial update for 18F-fluoroestradiol PET/CT in breast cancer.
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Pilot Study Using Molecular Profiling to Find Potential Targets & Select Treatments for Pts With Met br ca [EARLY_Phase 1]
Pilot early-phase study exploring molecular profiling to identify targets and tailor treatments for metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: IMX-110 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update for IMX-110 in adults with advanced solid tumors across Phase 1 and Phase 2 is listed, with multiple solid tumor ind…
-
CLINICAL_TRIALS trial_result · 2023-09-26Clinical Trial Update: Clinical Study of Huaier Granules in Patients With Advanced Breast Cancer Without Visceral Metastasis [Phase 4]
Phase 4 clinical study evaluating Huaier Granules in patients with advanced breast cancer without visceral metastasis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-09-25Clinical Trial Update: Exploratory Study of Advanced Breast Cancer in HER2 Positive Patients With Failure of Multi-line Therapy Treated by Combination of Inetetamab (Cipterbin) + PD-1 Inhibitor Combined With Utidelone. [Phase 2]
Phase 2 exploratory trial evaluating Inetetamab (Cipterbin) + PD-1 inhibitor with Utidelone in HER2-positive metastatic breast cancer after …
-
CLINICAL_TRIALS trial_result · 2023-09-25Clinical Trial Update: A Study of Pyrotinib Plus Capecitabine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating pyrotinib plus capecitabine for brain metastases in HER2-positive metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2023-09-25Clinical Trial Update: Treatment of Dalpiciclib Combined With Pyrotinib for Trastuzumab-sensitive HER2+ Advanced Breast Cancer(DAP-Her-02) [Phase 2]
Phase 2 clinical trial update investigating dalpiciclib combined with pyrotinib in trastuzumab-sensitive HER2-positive advanced breast cance…
-
CLINICAL_TRIALS trial_result · 2023-09-25Clinical Trial Update: Anlotinib Combination With Vinorelbine in the HER2- Advanced Breast Cancer [Phase 2]
Phase 2 trial investigating anlotinib in combination with vinorelbine for HER2-negative advanced breast cancer.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: A Study Assessing the Safety and Effectiveness of IC2000 and SPY Fluorescence Imaging Systems (SPY-PHI) in the Visualization of Lymphatic Vessels and Identification of Lymph Nodes During Sentinel Lymph Node Biopsy in Subjects With Breast Cancer [Phase 3]
Phase 3 clinical trial evaluating IC2000 and SPY Fluorescence Imaging Systems for visualization of lymphatic vessels and identification of l…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery [Phase 1]
Phase 1 study of AZD8186, a PI3K-β inhibitor, in combination with docetaxel for patients with PTEN or PIK3CB-mutant advanced solid tumors, i…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Prevention Strategy for Pre-Menopausal Women at High Risk for Development of Breast Cancer [Phase 2]
Phase 2 clinical trial update on a prevention strategy for pre-menopausal women at high risk for breast cancer (terminated; results posted).
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: NeoadjuVAnt muLti-agENT Chemotherapy or Patritumab Deruxtecan With or Without endocrINE Therapy for High-risk HR+/HER2- Breast Cancer - VALENTINE Trial [Phase 2]
A Phase 2 trial update for neoadjuvant multi-agent chemotherapy or patritumab deruxtecan with or without endocrine therapy in high-risk HR+/…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Study of KN026 Monotherapy or Combination Therapy in Patients With Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial update of KN026 as monotherapy or in combination for metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: CAELYX® as Adjuvant Treatment in Early Stage Luminal B Breast Cancer BREAST CANCER [Phase 2]
A Phase 2 clinical trial evaluating CAELYX® as adjuvant treatment in early-stage Luminal B breast cancer.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Electro-acupuncture for the Prevention of Taxane Induced Myalgias and Neuropathy [NA]
Clinical trial update on electro-acupuncture for preventing taxane-induced myalgias and neuropathy in breast cancer patients; study complete…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Proton Therapy for Early Stage Breast Cancer [NA]
Clinical trial update on proton therapy for early-stage breast cancer, with results posted.
-
CLINICAL_TRIALS trial_result · 2023-09-15Clinical Trial Update: A Phase Ib/II Study of SHR-A1811 Injection in Breast Cancer [Phase 2]
A Phase Ib/II clinical trial update for SHR-A1811 injection in breast cancer (Phase 2).
-
CLINICAL_TRIALS trial_result · 2023-09-14Clinical Trial Update: Randomized Phase 2 Study of Atezolizumab and Entinostat in Patients With aTN Breast Cancer With Phase 1b Lead In [Phase 1, Phase 2]
A randomized Phase 2 study evaluating the combination of atezolizumab and entinostat in advanced triple-negative breast cancer with a Phase …
-
CLINICAL_TRIALS trial_result · 2023-09-14Clinical Trial Update: Inetetamab Combined With Pyrotinib Plus Oral Vinorelbine for the Treatment of HER2-positive Metastatic Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating Inetetamab in combination with Pyrotinib and oral Vinorelbine for HER2-positive metastatic breast cancer…
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer [Phase 2]
Phase 2 trial evaluating carboplatin with or without atezolizumab in Stage IV triple-negative breast cancer completed; results were posted i…
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: Study of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer (MK-7962-012) [Phase 2]
A Phase 2 clinical trial evaluating sotatercept for chemotherapy-induced anemia in metastatic breast cancer was terminated; results posted i…
-
CLINICAL_TRIALS trial_result · 2023-09-11Clinical Trial Update: Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer [Phase 1]
Phase 1 trial evaluating chemokine modulation therapy in combination with standard chemotherapy before surgery for early-stage triple-negati…
-
CLINICAL_TRIALS trial_result · 2023-09-08Clinical Trial Update: Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer [NA]
Completed clinical trial investigating promotion of breast cancer screening in women who survived childhood cancer; results posted.
-
CLINICAL_TRIALS trial_result · 2023-09-07Clinical Trial Update: PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA) [Phase 2]
Phase 2 trial updating palbociclib rechallenge in hormone receptor–positive/HER2-negative advanced breast cancer has completed.